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Prison populations have grown worldwide, and now 
exceed 10 million people globally.1 Although some 
countries have clear and independent mechanisms 
of inspection, scant information is available about 
the conditions in which many prisoners are held. By 
necessity, published work in prisons represents a skewed 
sample of those countries from which evidence is 
made available. We must bear this discrepancy in mind 
because we know so little.
What we do know is that prisoners have high levels of 
mental health morbidity.2 Suicide is the prevailing cause 
of death in prison worldwide, with mortality rates more 
than three times higher than the general population.3 
The risk of death is highest in the early period after 
prison reception.4 In male prisoners, deaths occur most 
typically in local adult prisons that take people directly 
from the courts, whereas self-harm happens widely in 
female prisons.5 Mental disorder, substance misuse, white 
ethnic origin, violent oﬀ ending, awaiting trial, and having 
suicidal ideas are risk factors for death, many of which 
are common globally.6 Although most risk factors for 
suicide are also prevalent in the general population, their 
frequency in prison is alarming.2
Writing in The Lancet, Keith Hawton and colleagues7 
provide important conﬁ rmation of risk factors for 
self-harm and suicide in prison. They did a 6-year 
epidemiological study in the prison population of 
England and Wales and recorded 139 195 self-harm 
incidents among 26 510 prisoners over 5 years. High 
annual self-harm rates were noted, in 5–6% of male 
inmates and 20–24% of female prisoners. Self-harm 
incidents accumulated in younger people and those 
of white ethnic origin, and an association was noted 
with prison type, serving a life sentence, or being 
unsentenced. Violent oﬀ ending behaviour raised the 
risk of self-harm in female prisoners, and recurrence 
was common. The reported clustering of self-harm in 
time and location (adjusted intra-class correlation 0·15, 
95% CI 0·11–0·18) highlights the importance of the 
priso n context in understanding self-harm.
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Hawton and colleagues showed a temporal link 
between self-harm and completed suicide; 109 suicides 
in prison were reported in individuals who self-harmed, 
and more than half the deaths occurred within a month 
of self-harm. These ﬁ ndings indicate the importance 
of swift intervention after an incident of self-harm, 
and this work has already had an eﬀ ect on the way the 
Prison Service in England and Wales manages people 
at risk.8 The risk factors identiﬁ ed for self-harm are 
similar to those identiﬁ ed elsewhere for suicide, thereby 
challenging the notion that self-harming behaviour 
and suicide might represent diﬀ erent entities: instead, 
a direct link seems to exist for many prisoners. Hawton 
and colleagues make a vital contribution to answering 
the questions of who self-harms and how often does it 
happen, which complements previous work to address 
why people self-harm and what methods work to 
reduce self-harm and suicidal behaviour.9,10 However, 
additional work is now needed to address these ques-
tions, to reduce self-harm in prison further.5
Although this work by Hawton and colleagues will assist 
practice in prisons in England and Wales, a broad range 
of risk factors have been incorporated into assessment 
training and processes provided by the Prison Service 
for some years.8 To mitigate against diminishing returns 
through expansion, we need to understand why most 
prisoners do not self-harm and why some who harm 
themselves are propelled towards suicide whereas others 
are not. The answers to these questions do not necessarily 
sit with further examination of over-represented groups, 
but instead could be studied by focusing on process,3 
including speciﬁ c investigation of prisoners from groups 
with enhanced vulnerabilities—eg, inmates who are 
foreign nationals, or people with neurodevelopmental 
problems, including those with learning diﬃ  culties. For 
many individuals, including 102 female prisoners reported 
by Hawton and colleagues who accounted for around 
17 000 self-harming incidents, an examination that goes 
beyond generalised risk factors is crucial.
In England and Wales, a welcome and sustained 
reduc tion in the overall number of self-inﬂ icted prison 
deaths has been noted, from 96 in 2004 to 60 in 2012.4 
This fall has happened after several initiatives were 
introduced, including safer custody measures through 
the ACCT (Assessment, Care in Custody, and Teamwork) 
process,8 enhanced mental health services, and piece meal 
environmental improvements. Although dis entangling 
speciﬁ c causal factors can be diﬃ  cult from a pure research 
perspective, in view of confounders, the evaluative focus 
of the Independent Advisory Panel on Deaths in Custody 
allows cautious optimism. With attention now turning 
to self-harm management, avail able evidence indicates 
a key role for multi-agency collaboration, in which 
“suicide is everyone’s concern”,11 rather than being the 
sole preserve of health-care staﬀ . As such, collaboration 
between organisations—with responsibility held jointly—
could be an important preventive measure, for both self-
harm and suicide. Prison oﬃ  cers can provide practical 
support, which could calm distress and play a central 
part in identiﬁ cation and management of risk, and 
have a key role in recognition of undetected psychiatric 
morbidity.12 To harness this potential and thereby avoid 
so-called silo working, a focus on eﬀ ective joint systems 
and a widening of the scope of specialist training and 
supervision (currently only available to a few prison 
workers in the UK) is recommended.
Despite clear gains in the care of prisoners and pre-
vention of self-harm and suicide in prisons in England 
and Wales, much work remains to be done. Linking 
epidemiological samples and ground-level improve ments 
is not easy. A renewed approach is needed that seeks 
to understand better the connection between suicidal 
ideation and completed suicide. We need to invest in 
the wide inclusion of all people who, on the ground, can 
listen to prisoners who are experiencing distress, mobilise 
concern, and help to deliver joined-up care.
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The London School of Hygiene and Tropical Medicine, 
University College London, the European Public Health 
Association, and The Lancet invite abstract submissions 
for Public Health Science: A National Conference 
Dedicated to New Research in UK Public Health, to 
be held on Nov 19, 2014. Now in its third year, this 
multidisciplinary event showcases exceptional talent 
in the UK public health research community from early 
career researchers through to senior academics. This year 
we are delighted to hold the event in association with 
the European Public Health Association in Glasgow, UK. 
Work completed outside the UK can be submitted to 
the conference; however, abstracts relevant to UK public 
health science will be prioritised.
The core of the event will consist of submitted papers, 
and will conclude with keynote presentations from 
leaders in public health. The peer-reviewed abstracts will 
be published by The Lancet, online and in a conference 
booklet. Abstracts can be submitted under any of the 
following three themes: creativity and innovation in 
public health science; new methodological approaches 
to public health science; and implementing public 
health science in policy and practice. Further details on 
the programme for the day and topics can be found on 
the conference website.
Abstracts should be a maximum of 300 words, be 
written in English, and contain no references, tables, 
or ﬁ gures. Submissions should include the following 
sections: background (including context and aim); 
methods; ﬁ ndings; and interpretation. Please also 
include a non-declamatory title (including a study 
descriptor—eg, randomised controlled trial); names, 
titles, highest degrees, and aﬃ  liations of authors; postal 
and email addresses for the corresponding author; 
any funding received (if none, please state this); and a 
brief summary of the contributions of each author and 
any competing interests. Guidelines are available on 
The Lancet’s website. Reports of randomised trials should 
follow the CONSORT extension for abstracts.
Please submit your abstract as a Microsoft Word 
document to The Lancet’s online submission system, 
stating in your covering letter that the submission is 
for the Public Health Science conference, no later than 
June 27, 2014. After the Lancet peer-review process, 
participants will be informed of acceptance of abstracts 
for oral or poster presentation by Aug 27, 2014.
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